Sun Denies Insider Trading ... | Chemical & Engineering News
Volume 92 Issue 19 | p. 16 | Concentrates
Issue Date: May 12, 2014

Sun Denies Insider Trading ...

Department: Business
Keywords: India, generics, insider, FDA, cGMP

Indian generic drug producer Sun Pharmaceutical Industries has denied allegations that one of its subsidiaries had access to inside information when it bought shares in Ranbaxy Laboratories. Indian stock traders and investors complained about a mysterious rise in the price of Ranbaxy’s shares a few days before Sun announced last month that it had agreed to acquire the firm (C&EN, April 14, page 6). In a statement to the National Stock Exchange of India, Sun claims that although its subsidiary, Silverstreet Developers, had acquired Ranbaxy shares, it had done so in the course of its normal operations and without access to nonpublic information.

Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment